Evergreen Pharmaceutical Cincinnati, OH - 45202

Evergreen Pharmaceutical is categorized under Drugs, Proprietaries, and Sundries in Cincinnati, OH and active since 2007.

Evergreen Pharmaceutical was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.

If you are seeking more information, feel free to contact Regis T Robbins at the company’s single location by writing to 201 East 4th St # 1500, Cincinnati, Ohio OH 45202 or by phoning (513) 719-0851. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Evergreen Pharmaceutical
Contact Person: Regis T Robbins
Address: 201 East 4th St # 1500, Cincinnati, Ohio 45202
Phone Number: (513) 719-0851
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Drugs, Proprietaries, and Sundries
SIC Code: 5122
NAICS Code: 424210
Share This Business:

Evergreen Pharmaceutical was started in 2007 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Regis T Robbins for inquiries that concern Evergreen Pharmaceutical by calling the company number (513) 719-0851, as your correspondence is most welcome. Additionally, the physical location of the single location of Evergreen Pharmaceutical can be found at the coordinates 39.100396,-84.508594 as well as the street address 201 East 4th St # 1500 in Cincinnati, Ohio 45202.

For its online presence, you may visit Evergreen Pharmaceutical’s website at and engage with its social media outlets through on Twitter and on Facebook.